Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study (Q46738435)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study |
scientific article |
Statements
1 reference
Short-term safety and tolerability of a once-daily fixed-dose abacavir-lamivudine combination versus twice-daily dosing of abacavir and lamivudine as separate components: findings from the ALOHA study (English)
1 reference
Calvin J Cohen
1 reference
Marshall Kubota
1 reference
Philip S Brachman
1 reference
William B Harley
1 reference
Stefan Schneider
1 reference
Vanessa C Williams
1 reference
Denise H Sutherland-Phillips
1 reference
Michael L Lim
1 reference
Rukmini B Balu
1 reference
Mark S Shaefer
1 reference
Abacavir-Lamivudine Once-Daily HIV Assessment (ALOHA) Study Group
1 reference
1 March 2008
1 reference
1 reference
28
1 reference
3
1 reference
314-322
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference